EGFR tyrosine kinase inhibitors in squamous cell lung cancer

Fred R. Hirsch; Roy S. Herbst; David R Gandara

doi:10.1016/S1470-2045(15)00126-6

EGFR tyrosine kinase inhibitors in squamous cell lung cancer

Fred R. Hirsch, Roy S. Herbst, David R Gandara

Hematology and Oncology

Research output: Contribution to journal › Article

6 Scopus citations

Original language	English (US)
Pages (from-to)	872-873
Number of pages	2
Journal	The Lancet Oncology
Volume	16
Issue number	8
DOIs	https://doi.org/10.1016/S1470-2045(15)00126-6
State	Published - Aug 1 2015

ASJC Scopus subject areas

Oncology

Access to Document

10.1016/S1470-2045(15)00126-6

Cite this

Hirsch, F. R., Herbst, R. S., & Gandara, D. R. (2015). EGFR tyrosine kinase inhibitors in squamous cell lung cancer. The Lancet Oncology, 16(8), 872-873. https://doi.org/10.1016/S1470-2045(15)00126-6

@article{7240b394bff34c8b98b0c7ff10ad5098,

title = "EGFR tyrosine kinase inhibitors in squamous cell lung cancer",

author = "Hirsch, {Fred R.} and Herbst, {Roy S.} and Gandara, {David R}",

year = "2015",

month = aug,

day = "1",

doi = "10.1016/S1470-2045(15)00126-6",

language = "English (US)",

volume = "16",

pages = "872--873",

journal = "The Lancet Oncology",

issn = "1470-2045",

publisher = "Lancet Publishing Group",

number = "8",

}

TY - JOUR

T1 - EGFR tyrosine kinase inhibitors in squamous cell lung cancer

AU - Hirsch, Fred R.

AU - Herbst, Roy S.

AU - Gandara, David R

PY - 2015/8/1

Y1 - 2015/8/1

UR - http://www.scopus.com/inward/record.url?scp=84938203170&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84938203170&partnerID=8YFLogxK

U2 - 10.1016/S1470-2045(15)00126-6

DO - 10.1016/S1470-2045(15)00126-6

M3 - Article

C2 - 26156654

AN - SCOPUS:84938203170

VL - 16

SP - 872

EP - 873

JO - The Lancet Oncology

JF - The Lancet Oncology

SN - 1470-2045

IS - 8

ER -